Voglimet GM 1mg/500mg/0.2mg Tablet SR
Marketer
Leeford Healthcare Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimet GM 1mg/500mg/0.2mg Tablet SR
Diabetics using the anti-diabetic medication, Voglimet GM 1mg/500mg/0.2mg SR tablets (extended release), should adhere to their physician's prescribed dosage and regimen. This combination drug manages type 2 diabetes in adults by regulating blood glucose. Consistent daily intake, always with food, maximizes efficacy. Dosage adjustments are common, based on individual blood sugar monitoring. Discontinuing the medication without medical consultation risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medicine is only one element of a comprehensive diabetes management plan; a healthy diet, regular exercise, and weight management, as directed by your doctor, are crucial. Common side effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. To mitigate this risk, maintain regular mealtimes and carry readily available glucose sources (e.g., sugary foods, fruit juice). Alcohol consumption should be minimized due to its interaction with the drug. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Pre-existing heart conditions should be disclosed to your physician before commencing treatment. Similar consultation is advised for pregnant or breastfeeding individuals. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential components of treatment.
Uses of Voglimet GM 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglimet GM 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimet GM 1mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer this extended-release tablet on an empty stomach.
Common Side effects of Voglimet GM 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglimet GM 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Voglimet GM 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
How Voglimet GM 1mg/500mg/0.2mg Tablet SR works:
Voglimet GM SR tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimet GM 1mg/500mg/0.2mg Tablet SR with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Voglimet GM 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglimet GM tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Voglimet GM 1mg/500mg/0.2mg SR tablets in individuals with kidney impairment carries a high risk and is best avoided. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglimet GM 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; Voglimet GM 1mg/500mg/0.2mg SR tablets are unsuitable for patients with severe liver disease.
What if you forget to take Voglimet GM 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Voglimet GM 1mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimet GM 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently